6th Nov 2015 13:27
For immediate release | 6 November 2015 |
ABCAM PLC
("Abcam" or "the Company")
Director/PDMR Shareholding: LTIP
Cambridge, UK: Abcam plc (AIM: ABC), a global leader in the supply of life science research tools, announces that on 5 November 2015 the Remuneration Committee granted the following share awards in the form of Nil Cost Options or Conditional Shares ("Award") to the Directors of the Company under the Abcam plc Long-Term Incentive Plan ("LTIP"):
Director | Number of 0.2 pence Ordinary Shares subject to the LTIP Award
|
Alan Hirzel | 66,212* |
Jim Warwick | 43,671 |
* The award made to Alan Hirzel is in the form of conditional shares which will be delivered following vesting.
The Awards will vest in three years' time subject to continued employment and subject to a performance condition based on growth in earnings per share. Additional post-vesting holding periods apply to these awards.
The Remuneration Committee also granted the following joining share award in the form of Nil Cost Options to the following PDMR of the Company under the Abcam plc LTIP:
PDMR:
Name | Number of 0.2 pence Ordinary Shares subject to the LTIP Award
|
Suzanne Smith | 54,242 |
This award will vest on 6 July 2018 subject to continued employment.
For further information please contact:
Abcam | + 44 (0) 1223 696 000 |
Suzanne Smith, Company Secretary
| |
J.P.Morgan Cazenove - Nominated Adviser & Corporate Broker | + 44 (0) 20 7742 4000 |
James Mitford / Alex Bruce - Nominated Adviser | |
Notes to Editors
About Abcam
Abcam plc is a global leader in the supply of life science research tools, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.
Abcam is committed to providing scientists with an extensive choice of reagents and tools, with the most comprehensive, honest and up-to-date datasheets and customer reviews, fast delivery and helpful customer service & technical support. The Company's catalogue evolves with scientific research trends and is growing each year to provide customers with products to meet their research needs. The range now includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam also supports its customers by hosting a range of global scientific events, forums and webinars, providing opportunities for scientists to get together and present their work.
Headquartered in Cambridge, UK, Abcam has nine global subsidiary offices enabling local services and multi-language support and sells to over 100 countries. The Company was founded in 1998, and now employs over 820 people. Abcam was admitted to AIM in 2005 (AIM: ABC).
To find out more, please visit www.abcam.com
Related Shares:
ABC.L